Applications of recombined Ganoderma lucidum immunoregulation protein in preparing drugs for treating tissue fibrosis
AssigneesXitian Zhang, Fei Sun
InventorsXitian Zhang, Fei Sun, Chongyang Liang
Life of this patent
Estimating the term…
Abstract
Applications of recombined ganoderma lucidum immunoregulation protein (rLZ-8) in preparing drugs for treating tissue fibrosis are provided.
Claims2
A method for treatment of the tissue fibrosis induced by any reason or diseases via applying a therapeutically effective amount of Ganoderma lucidum immunoregulation protein (rLZ-8), wherein the therapeutically effective amount of Ganoderma lucidum immunoregulation protein (rLZ-8) further comprises a medicinally acceptable amount of adjuvant.
A method for treatment of the tissue fibrosis induced by any reason or diseases via applying a therapeutically effective amount of Ganoderma lucidum immunoregulation protein (rLZ-8), wherein an administration of Ganoderma lucidum immunoregulation protein (rLZ-8) for treatment is by oral or parenteral route;
- Ganoderma lucidum immunoregulation protein (rLZ-8) for treatment is prepared as oral solution, tablets, pills, capsules or other forms for oral administration;
- and externally applied Ganoderma lucidum immunoregulation protein (rLZ-8) as injections or other forms for parenteral route.
Dependencies are inferred from the claim text.